SCAN 2025 – NET patient survey (New Zealand)
The New Zealand reading of the global SCAN 2025 survey of neuroendocrine cancer patients and clinicians – how our care compares with the world.
SCAN (Survey on the Challenges faced by patients and clinicians Affected by NETs) is a global survey run every few years. In 2025, 110 New Zealand patients and 73 clinicians took part. The results show where New Zealand leads – free, nurse-led care and world-class PRRT access – and where we fall behind, on treatment delays and awareness of clinical trials.
View the interactive SCAN 2025 report, or download the full PDF.
Related resources
More like this →
VideoUnderstanding neuroendocrine care in New Zealand – Ben Lawrence
How neuroendocrine cancer care is organised in New Zealand, and what that means for the people in it.
VideoSIRT – Dr Sofiullah Abubakar and Dr Michael Sunderland
A Zoom session on selective internal radiation therapy (SIRT), for anyone who could not join on the night.
VideoMerkel Cell Carcinoma – Ben Lawrence
Merkel Cell Carcinoma, a rare neuroendocrine cancer of the skin, explained for patients and whānau.
BookletPatient Guide
This booklet has been developed to provide information about neuroendocrine tumours (NETs) for patients and their families.